A phase 1 trial to determine the maximum tolerated dose and patient-specific dosimetry of [177Lu]Lu-LNC1003 in patients with metastatic castration-resistant prostate cancer
Jie Zang, Guochang Wang, Tianzhi Zhao, Huipan Liu, Xiuting Lin, Yun Yang, Zezhong Shao, Chao Wang, Haojun Chen, Yue Chen, Zhaohui Zhu, Weibing Miao, Xiaoyuan Chen, Jingjing Zhang
Topics & Concepts
MedicineProstate cancerNuclear medicineDosimetryUrologyEffective dose (radiation)CancerInternal medicineProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsProstate Cancer Diagnosis and Treatment